Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer
- PMID: 32857949
- DOI: 10.1016/j.ccell.2020.07.011
Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer
Abstract
In a recent Nature article, Middleton et al. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment on
-
The National Lung Matrix Trial of personalized therapy in lung cancer.Nature. 2020 Jul;583(7818):807-812. doi: 10.1038/s41586-020-2481-8. Epub 2020 Jul 15. Nature. 2020. PMID: 32669708 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources